|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the OMPI 10-Q filed Aug 11, 2008. Interest rate risk Our interest income and expense is more sensitive to fluctuations in the general level of U.S. prime rate and LIBOR interest rates than to changes in rates in other markets. Changes in U.S. 27 LIBOR interest rates affect the interest earned on our cash and cash equivalents. At June 30, 2008, we had approximately $23.2 million of cash and cash equivalents. If the interest rates on our cash and cash equivalents were to increase or decrease by 1% for the year, annual interest income would increase or decrease by approximately $0.2 million. This excerpt taken from the OMPI 10-Q filed May 8, 2008. Interest rate risk Our interest income and expense is more sensitive to fluctuations in the general level of U.S. prime rate and LIBOR interest rates than to changes in rates in other markets. Changes in U.S. LIBOR interest rates affect the interest earned on our cash and cash equivalents. At March 31, 2008, we had approximately $21.3 million of cash and cash equivalents. If the interest rates on our cash and cash equivalents were to increase or decrease by 1% for the year, annual interest income would increase or decrease by approximately $0.2 million. These excerpts taken from the OMPI 10-K filed Mar 4, 2008. Interest rate risk Our interest income and expense is more sensitive to fluctuations in the general level of U.S. prime rate and LIBOR interest rates than to changes in rates in other markets. Changes in U.S. LIBOR interest rates affect the interest earned on our cash and cash equivalents. At December 31, 2007, we had approximately $14.1 million of cash and cash equivalents. If the interest rates on our cash and cash equivalents were to increase or decrease by 1% for the year, annual interest income would increase or decrease by approximately $0.1 million. We purchased a LIBOR interest rate cap agreement as an economic hedge against our Credit Agreement borrowings. The interest rate cap is 6.0% on a decreasing notional amount starting at $35.0 million decreasing to approximately $34.0 million. This agreement expires on January 1, 2008. We reflected the cap on the consolidated balance sheet at its fair market value and any change in fair value is reported in interest expense. As we paid the remaining balance of our Credit Agreement borrowings upon the consummation of our Secondary Offering completed on October 12, 2007, the fair value of the interest rate cap was $0 as of December 31, 2007. Interest rate risk Our interest income and expense is more sensitive to fluctuations in the general level of U.S. prime rate and LIBOR interest rates than to changes in rates in We This excerpt taken from the OMPI 10-Q filed Nov 14, 2007. Interest rate risk Our interest income and expense is more sensitive to fluctuations in the general level of U.S. prime rate and LIBOR interest rates than to changes in rates in other markets. Changes in U.S. LIBOR interest rates affect the interest earned on our cash and cash equivalents and the interest expense on our debt. At September 30, 2007, we had approximately $7.0 million of variable rate debt. If the interest rates on the variable rate debt were to increase or decrease by 1% for the year, annual interest expense would increase or decrease by approximately $0.1 million. In March 2005, we purchased a LIBOR interest rate cap agreement as an economic hedge against our Facility borrowings. The interest rate cap is 6.0% on a decreasing notional amount starting at $35.0 million decreasing to approximately $34.0 million. This agreement expires on January 1, 2008. We reflected the cap on the consolidated Balance Sheet at its fair market value and any change in fair value is reported in interest expense. As of September 30, 2007, the fair value of the interest rate cap was $0. The Company completed a registered public offering on October 17, 2007. The offering was priced at $20.00 per share with a 5.5% underwriting discount. In the offering the Company sold 800,000 shares of common stock and received net proceeds of $15.1 million. The Company used a portion of the proceeds from this offering to repay all outstanding Term A and Term B debt under the Facility. No gain or loss on extinguishment of the debt was incurred. Deferred financing costs of $0.2 million related to the Term A and B notes were written off upon the extinguishment and recorded as interest expense. This excerpt taken from the OMPI 10-Q filed Aug 7, 2007. Interest rate risk Our interest income and expense is more sensitive to fluctuations in the general level of U.S. prime rate and LIBOR interest rates than to changes in rates in other markets. Changes in U.S. LIBOR interest rates affect the interest earned on our cash and cash equivalents and the interest expense on our debt. At June 30, 2007, we had approximately $9.7 million of variable rate debt. If the interest rates on the variable rate debt were to increase or decrease by 1% for the year, annual interest expense would increase or decrease by approximately $0.1 million. In March 2005, we purchased a LIBOR interest rate cap agreement as an economic hedge against our Facility borrowings. The interest rate cap is 6.0% on a decreasing notional amount starting at $35.0 million decreasing to approximately $34.0 million. This agreement expires on January 1, 2008. We reflected the cap on the consolidated Balance Sheet at its fair market value and any change in fair value is reported in interest expense. As of June 30, 2007, the fair value of the interest rate cap was $0. This excerpt taken from the OMPI 10-Q filed May 8, 2007. Interest rate risk Our interest income and expense is more sensitive to fluctuations in the general level of U.S. prime rate and LIBOR interest rates than to changes in rates in other markets. Changes in U.S. LIBOR interest rates affect the interest earned on our cash and cash equivalents and the interest expense on our debt. At March 31, 2007, we had approximately $25.7 million of variable rate debt. If the interest rates on the 24 variable rate debt were to increase or decrease by 1% for the year, annual interest expense would increase or decrease by approximately $0.3 million. In March 2005, we purchased a LIBOR interest rate cap agreement as an economic hedge against our Credit Agreement borrowings. The interest rate cap is 6.0% on a decreasing notional amount starting at $35.0 million decreasing to approximately $34.0 million. This agreement expires on January 1, 2008. We reflected the cap on the consolidated Balance Sheet at its fair market value and any change in fair value is reported in interest expense. As of March 31, 2007, the fair value of the interest rate cap was $0. This excerpt taken from the OMPI 10-K filed Mar 15, 2007. Interest rate risk Our interest income and expense is more sensitive to fluctuations in the general level of U.S. prime rate and LIBOR interest rates than to changes in rates in other markets. Changes in U.S. LIBOR interest rates affect the interest earned on our cash and cash equivalents and the interest expense on our debt. At December 31, 2006, we had approximately $25.7 million of variable rate debt. If the interest rates on the variable rate debt were to increase or decrease by 1% for the year, annual interest expense would increase or decrease by approximately $0.3 million. We purchased a LIBOR interest rate cap agreement as an economic hedge against our Credit Agreement borrowings. The interest rate cap is 6.0% on a decreasing notional amount starting at $35.0 million decreasing to approximately $34.0 million. This agreement expires on January 1, 2008. We reflected the cap on the consolidated balance sheet at its fair market value and any change in fair value is reported in interest expense. As of December 31, 2006, the fair value of the interest rate cap was approximately $3,000. | EXCERPTS ON THIS PAGE:
|
| |||||||
